|
Pronunciation |
|
(sye
METH i
kone) |
|
|
U.S. Brand
Names |
|
Degas®[OTC]; Flatulex®[OTC]; Gas
Relief®; Gas-X®[OTC]; Maalox® Anti-Gas [OTC];
Mylanta® Gas [OTC]; Mylicon®[OTC];
Phazyme®[OTC] |
|
|
Generic
Available |
|
Yes: Tablet |
|
|
Synonyms |
|
Activated Dimethicone; Activated Methylpolysiloxane |
|
|
Pharmacological Index |
|
Antiflatulent |
|
|
Use |
|
Relieves flatulence and functional gastric bloating, and postoperative gas
pains |
|
|
Pregnancy Risk
Factor |
|
C |
|
|
Contraindications |
|
Hypersensitivity to simethicone or any component |
|
|
Adverse
Reactions |
|
No data reported |
|
|
Drug
Interactions |
|
No data reported |
|
|
Stability |
|
Protect from light |
|
|
Mechanism of
Action |
|
Decreases the surface tension of gas bubbles thereby disperses and prevents
gas pockets in the GI system |
|
|
Usual Dosage |
|
Oral:
Children <12 years: 40 mg 4 times/day
Children >12 years and Adults: 40-120 mg after meals and at bedtime as
needed, not to exceed 500 mg/day |
|
|
Dietary
Considerations |
|
Avoid carbonated beverages and gas-forming foods; should be administered
after meals |
|
|
Administration |
|
Shake suspension before using; mix with water, infant formula, or other
liquids |
|
|
Mental Health: Effects
on Mental Status |
|
None reported |
|
|
Mental Health:
Effects on Psychiatric
Treatment |
|
None reported |
|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
No information available to require special precautions |
|
|
Dental Health:
Effects on Dental Treatment |
|
No effects or complications reported |
|
|
Patient
Information |
|
Some tablets may be chewed thoroughly before swallowing, follow with a glass
of water |
|
|
Nursing
Implications |
|
Shake suspension before using; mix with water, infant formula or other
liquids |
|
|
Dosage Forms |
|
Capsule: 125 mg
Drops, oral: 40 mg/0.6 mL (30 mL)
Tablet: 50 mg, 60 mg, 95 mg
Chewable: 40 mg, 80 mg, 125 mg
|
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|